A ranked comparison of MedTech and medical devices market research firms serving Poland in 2026. For regional context, start from the healthcare market research hub and healthcare market research in Poland.
For company-intent programmes, see our MedTech market research company in Poland page and the Poland market intelligence briefing.
The Poland medical devices market is estimated at PLN 18–22 billion in 2026, shaped by URPL regulation, hospital procurement cycles, and Polmedica and growing domestic manufacturing base. Manufacturers launching or defending device portfolios need primary research that maps prescriber behaviour to committee and payer reality — not syndicated averages alone.
MedTech market research in Poland differs from pharmaceutical research: sample frames prioritise biomedical engineers, hospital value-analysis committees, and procedure specialists; evidence must address total cost of ownership, training burden, and maintenance contracts alongside clinical efficacy.
Global syndicated vendors provide audit data; specialist firms like BioNixus add verified hospital access, URPL-aware study design, and decision-linked synthesis for launch sizing, competitive defence, and international expansion planning.
For company-intent programmes — not firm comparison — see our dedicated MedTech market research page for Poland. For broader healthcare context, start from the healthcare market research hub and /healthcare-market-research-poland.
International MedTech Specialist · USA (HQ) / UK / Egypt
BioNixus delivers MedTech and medical devices market research in Poland with URPL-aware hospital procurement research, clinician adoption studies, and decision-ready synthesis. See the dedicated company page at /poland-medtech-market-research.
Global Life Sciences Data · USA (global)
IQVIA provides medical device market analytics, hospital audit data, and custom primary research in Poland through its global life sciences network.
Global Network · UK (global)
Kantar operates custom and syndicated research in Poland with healthcare and B2B practices supporting MedTech brand tracking and physician insight programmes.
Global Network · France (global)
Ipsos delivers healthcare and device market research in Poland with quantitative rigour and public affairs capability for regulated categories.
Local / Regional · Poland and international
Several regional boutiques execute MedTech fieldwork in Poland. Validate device-specific methodology, hospital access, and URPL context before award.
Leading options include BioNixus, IQVIA, Kantar, Ipsos, and regional specialist agencies serving Poland. BioNixus ranks first for URPL-aware hospital procurement research and clinician adoption studies.
Validate hospital access, device category experience, sample verification controls, regulatory context, and decision-ready deliverables — not slide volume alone.
This guide covers MedTech and medical devices industry selection. For pharmaceutical company-intent pages, use /healthcare-market-research-poland and related healthcare BOFU URLs.
See /poland-medtech-market-research for company-intent MedTech market research programmes; this listicle compares firms independently.
Yes. BioNixus runs parallel modules comparing local adoption with SFDA, MOHAP, and GCC hospital procurement intelligence using harmonised instruments.
Cardiovascular, orthopaedics, diagnostic imaging, IVD, diabetes technology, surgical robotics, wound care, and hospital capital equipment — segment feasibility should be validated at proposal stage.
Focused HCP surveys complete in four to six weeks; full mixed-method programmes with hospital procurement depth typically run eight to twelve weeks depending on specialty and geography.
Yes. Rankings and capability notes reflect Poland regulatory and procurement context as of 2026, including URPL requirements.
Compare MedTech research needs with our pages for Germany and United Kingdom, or explore the global healthcare market research hub.
Our team supports pharmaceutical companies with decision-ready insights across the Americas, Europe, and the Middle East using quantitative and qualitative methodologies.
US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323